| This Friday, a group of vaccine and infectious disease experts will assemble virtually to discuss whether the Food and Drug Administration should clear Johnson & Johnson’s coronavirus vaccine for emergency use. Experts are likely to debate emerging issues like protection against new virus variants. The meeting will be broadcast through an FDA conference system as well as on Youtube. Here’s what to watch for: More details on the effectiveness of J&J’s vaccine, a window into the FDA’s view on vaccine protection against variants, an update on J&J’s expected vaccine supply, and a comparison between two types of vaccine technology. |
